Humira is an immunosuppressive drug used to treat arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis, is one of the most profitable drugs of all time. In this episode, Tahir Amin, founder and executive director of the Initiative for Medicines, Access & Knowledge., joins Dr. Josh Sharfstein to talk about how gaming the patent system may have helped stave off competition, costing consumers billions of dollars. They also discuss what it would take to reform the system.